These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 891378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral carotene therapy in actinic reticuloid and solar urticaria. Failure to demonstrate a photoprotective effect against long wave ultraviolet and visible radiation.
    Kobza A, Ramsay CA, Magnus IA.
    Br J Dermatol; 1973 Feb; 88(2):157-66. PubMed ID: 4574773
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carotenoid treatment for light sensitivity: a reappraisal and six years' experience.
    Wennersten G.
    Acta Derm Venereol; 1980 Feb; 60(3):251-5. PubMed ID: 6158229
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. beta-Carotene in the treatment of erythropoietic protoporphyria. A short review.
    Krook G, Haeger-Aronsen B.
    Acta Derm Venereol Suppl (Stockh); 1982 Feb; 100():125-9. PubMed ID: 6819749
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of photosensitivity in congenital erythropoietic porphyria (CEP) with beta-carotene.
    Seip M, Thune PO, Eriksen L.
    Acta Derm Venereol; 1974 Feb; 54(3):239-40. PubMed ID: 4134239
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
    Mathews-Roth MM.
    Biochimie; 1986 Jun; 68(6):875-84. PubMed ID: 3092881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria.
    Mathews-Roth MM, Pathak UA, Fitzpatrick TB, Harber LC, Kass EH.
    JAMA; 1974 May 20; 228(8):1004-8. PubMed ID: 4406335
    [No Abstract] [Full Text] [Related]

  • 16. Beta-carotene as a photoprotective agent in erythropoietic protoporphyria.
    Mathews-Roth MM, Pathak MA, Fitzpatrick TB, Harber LC, Kass EH.
    N Engl J Med; 1970 May 28; 282(22):1231-4. PubMed ID: 5442632
    [No Abstract] [Full Text] [Related]

  • 17. The quality of life of 790 patients with photodermatoses.
    Jong CT, Finlay AY, Pearse AD, Kerr AC, Ferguson J, Benton EC, Hawk JL, Sarkany RP, McMullen E, Rhodes LE, Farr PM, Anstey AV.
    Br J Dermatol; 2008 Jul 28; 159(1):192-7. PubMed ID: 18460025
    [Abstract] [Full Text] [Related]

  • 18. The effects of canthaxanthin on the photocutaneous manifestations of porphyria.
    Eales L.
    S Afr Med J; 1978 Dec 16; 54(25):1050-2. PubMed ID: 371027
    [Abstract] [Full Text] [Related]

  • 19. [Association of beta-carotene and canthaxanthine in the treatment of actinic reticuloid].
    Aratari E, Virno G, Desirello G, Nazzari G.
    Acta Vitaminol Enzymol; 1982 Dec 16; 4(4):319-24. PubMed ID: 6818856
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacological basis for the treatment of photodermatoses.
    Peyron JL, Meynadier J.
    Biochimie; 1986 Jun 16; 68(6):899-904. PubMed ID: 2944546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.